Diurnal variation in PAI-1 activity predominantly confined to the 4G-allele of the PAI-1 gene

被引:21
|
作者
Hoekstra, T
Geleijnse, JM
Schouten, EG
Kluft, C
机构
[1] Wageningen Univ, Div Human Nutr & Epidemiol, NL-6700 EV Wageningen, Netherlands
[2] TNO, Gaubius Lab, PG, Leiden, Netherlands
关键词
fibrinolysis; diurnal variation; PAI-1; t-PA; 4G/5G-polymorphism;
D O I
10.1055/s-0037-1613304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the diurnal pattern in Plasminogen Activator Inhibitor-type 1 (PAI-1) activity and Plasminogen activator (t-PA) in relation to the 4G/5G-polymorphism in the promoter of the PAI-1 gene. The analyses were performed in the Arnhem Elderly Study, a population-based study of 598 elderly. A single blood sample was drawn and the time of blood sampling was recorded (between 8 a. m. and 5.30 p. m.). Plasma PAI-1 activity was strongly associated with time of blood sampling, showing the highest values in the early morning. The diurnal pattern was clearly present in the 4GAG (n = 184) and 4G/5G (n = 275) genotypes, but not in the 5G/5G-genotype (n = 139). T-PA antigen showed a weak diurnal variation, which did not differ across the variants of the 4G/5G-polymorphism. Our findings raise the hypothesis that 5G-homozygotic persons may be relatively protected from diurnal variation in the occurrence of coronary events.
引用
收藏
页码:794 / 798
页数:5
相关论文
共 50 条
  • [21] STABILIZATION OF PAI-1 BY AN ANTIBODY SPECIFIC FOR ACTIVE PAI-1, COMPARED TO THE EFFECT OF VITRONECTIN
    EHNEBOM, J
    BJORQUIST, P
    PUSA, S
    DEINUM, J
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1009 - 1009
  • [22] tPA,PAI-1 and tPA/PAI-1 complex as rifactors for the development of a first stroke
    Boman, K
    Johansson, L
    Jansson, JH
    Stegmayr, B
    Hallmans, G
    CIRCULATION, 1999, 100 (18) : 181 - 181
  • [23] Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients
    Testa, R
    Bonfigli, AR
    Sirolla, C
    Boemi, M
    Manfrini, S
    Mari, D
    Testa, I
    Sacchi, E
    Franceschi, C
    DIABETES NUTRITION & METABOLISM, 2004, 17 (04) : 217 - 221
  • [24] The Effect of PAI-1 Gene Variants and PAI-1 Plasma Levels on Development of Thrombophilia in Patients With Klinefelter Syndrome
    Erkal, Burcin
    Yigin, Aysel Kalayci
    Palanduz, Sukru
    Dasdemir, Selcuk
    Seven, Mehmet
    AMERICAN JOURNAL OF MENS HEALTH, 2018, 12 (06) : 2152 - 2156
  • [25] Posttranscriptional regulation of PAI-1 gene expression
    Heaton, JH
    Dlakic, WM
    Gelehrter, TD
    THROMBOSIS AND HAEMOSTASIS, 2003, 89 (06) : 959 - 966
  • [26] The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo
    Van de Craen, Britt
    Declerck, Paul J.
    Gils, Ann
    THROMBOSIS RESEARCH, 2012, 130 (04) : 576 - 585
  • [27] REGULATION OF PAI-1 GENE-EXPRESSION
    LOSKUTOFF, DJ
    FIBRINOLYSIS, 1991, 5 (04) : 197 - 206
  • [28] Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
    Sillen, Machteld
    Declerck, Paul J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [29] Tintelize tPA•PAI-1, a new method for the measurement of TPA•-PAI-1 complexes
    Bergsdorf, N
    Wiman, B
    Norrman, B
    THROMBOSIS AND HAEMOSTASIS, 1999, : 123 - 123
  • [30] The influence of vitronectin and plasma on PAI-1 inactivation by different types of PAI-1 modulators
    Rupin, A
    Belzacq, AS
    de Nanteuil, G
    Verbeuren, TJ
    THROMBOSIS AND HAEMOSTASIS, 1999, : 324 - 324